00:00Biotech startup Intero Biosystems has taken top honors at TechCrunch Disrupt's 2026 startup battlefield with technology that could help transform
00:10how new drugs are tested.
00:12The company develops tiny lab-grown human intestinal tissues that pharmaceutical companies can use to study drug safety and how
00:21compounds affect the gut.
00:23The goal is to provide a more human-relevant alternative to animal testing, which doesn't always predict how medicines will
00:30work in people.
00:32Intero is still validating its technology, but its win marks a promising step forward in the push to make drug
00:38development more precise and less reliant on animal models.
